Scientific/research contact:
Christine Lee
240.402.4228
ChristineS.Lee@fda.hhs.gov

Objective review contact:
Shashi Malhotra
240.402.7592
Shashi.Malhotra@fda.hhs.gov

Financial and grants management contact:
Shashi Malhotra
240.402.7592
Shashi.Malhotra@fda.hhs.gov

This program will provide funding for innovative projects that will strengthen and advance COVID-19 health equity research.

Areas of interest include studies that:

• Leverage real world data to support evaluation of outcomes of FDA approved products, such as therapeutics, diagnostics, and vaccines, for the treatment, prevention, or diagnosis of COVID-19 by demographic data including, but not limited to, ethnicity, race, age, disability and geography
• Advance understanding of how to mitigate spread of COVID-19 misinformation and disinformation about science and medicine
• Leverage big data, novel data sources and artificial intelligence/machine learning options that contribute to the continued evaluation of the safety and efficacy of COVID-19 FDA-approved products by demographic data including, but not limited to, ethnicity, race, age, disability, and geography
• Continue to advance understanding of long COVID by demographic data including, but not limited to, ethnicity, race, age, disability and geography

Eligible applicants include:

• Higher education institutions
  • Public/state controlled institutions
  • Private institutions
• Nonprofit organizations
  • With 501(c)(3) status
  • Without 501(c)(3) status
  • Native American tribal organizations
  • Faith-based or community-based organizations
  • Regional organizations
• Governments
  • Federally recognized Indian/Native American tribal governments
  • Indian/Native American tribal governments (other than federally recognized)
  • U.S. territory or possession
• Other
  • Independent school districts
  • Public housing authorities
  • Indian housing authorities
  • Small businesses
  • For-profit organizations

Award ceiling: $500,000
Award floor: $50,000
Project period: 1 year
Estimated number of awards: 4

Links to the full announcement, application instructions, and the online application process are available through grants.gov.

While not required, potential applicants are encouraged to email a letter of intent to Shashi Malhotra by December 6, 2022. The application deadline is January 16, 2023.